| Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011 | 650 | 2011 |
| Genital inflammation and the risk of HIV acquisition in women L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ... Clinical Infectious Diseases 61 (2), 260-269, 2015 | 458 | 2015 |
| Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ... Nature medicine 22 (10), 1094-1100, 2016 | 298 | 2016 |
| Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response JM Cliff, JS Lee, N Constantinou, JE Cho, TG Clark, K Ronacher, EC King, ... The Journal of infectious diseases 207 (1), 18-29, 2013 | 277 | 2013 |
| A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ... Nature 560 (7720), 644-648, 2018 | 259 | 2018 |
| Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ... The Journal of infectious diseases 206 (1), 6-14, 2012 | 255 | 2012 |
| Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ... Sexually transmitted infections 90 (8), 580-587, 2014 | 214 | 2014 |
| Host blood RNA signatures predict the outcome of tuberculosis treatment EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ... Tuberculosis 107, 48-58, 2017 | 190 | 2017 |
| Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction K Ronacher, K Hadley, C Avenant, E Stubsrud, SS Simons Jr, A Louw, ... Molecular and cellular endocrinology 299 (2), 219-231, 2009 | 166 | 2009 |
| Synthetic progestins used in HRT have different glucocorticoid agonist properties D Koubovec, K Ronacher, E Stubsrud, A Louw, JP Hapgood Molecular and cellular endocrinology 242 (1-2), 23-32, 2005 | 153 | 2005 |
| Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus K Ronacher, SA Joosten, R van Crevel, HM Dockrell, G Walzl, ... Immunological reviews 264 (1), 121-137, 2015 | 147 | 2015 |
| Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment I Honeyborne, TD McHugh, PPJ Phillips, S Bannoo, A Bateson, N Carroll, ... Journal of clinical microbiology 49 (11), 3905-3911, 2011 | 143 | 2011 |
| Regulation of expression of mammalian gonadotrophin‐releasing hormone receptor genes JP Hapgood, H Sadie, W Van Biljon, K Ronacher Journal of neuroendocrinology 17 (10), 619-638, 2005 | 128 | 2005 |
| Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response HC Warsinske, AM Rao, FMF Moreira, PCP Santos, AB Liu, M Scott, ... JAMA network open 1 (6), e183779-e183779, 2018 | 125 | 2018 |
| Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis C Riou, B Perez Peixoto, L Roberts, K Ronacher, G Walzl, C Manca, ... PloS one 7 (5), e36886, 2012 | 122 | 2012 |
| Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: the TANDEM study C Ugarte-Gil, B Alisjahbana, K Ronacher, AL Riza, RC Koesoemadinata, ... Clinical Infectious Diseases 70 (5), 780-788, 2020 | 119 | 2020 |
| Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management JA Critchley, BI Restrepo, K Ronacher, A Kapur, AA Bremer, ... Chest 152 (1), 165-173, 2017 | 106 | 2017 |
| Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 2: underlying biologic mechanisms K Ronacher, R van Crevel, JA Critchley, AA Bremer, LS Schlesinger, ... Chest 152 (1), 174-180, 2017 | 94 | 2017 |
| Biomarkers for TB treatment response: challenges and future strategies G Walzl, K Ronacher, JFD Siawaya, HM Dockrell Journal of Infection 57 (2), 103-109, 2008 | 87 | 2008 |
| Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response JFD Siawaya, NB Bapela, K Ronacher, H Veenstra, M Kidd, R Gie, ... Journal of Infection 56 (5), 340-347, 2008 | 84 | 2008 |
AG LoxtonMedical ScientistVerified email at sun.ac.za
